Navigation Links
Study Finds GanedenBC30 Probiotic Supports Digestive and Immune Health in Healthy Seniors
Date:8/27/2013

Cleveland, OH (PRWEB) August 27, 2013

Ganeden Biotech, a recognized world leader in the manufacturing and marketing of probiotics, and Reckitt Benckiser (RB), announce that GanedenBC30 probiotic supports digestive and immune health in healthy seniors, according to research just released at the University of Reading, England.

The results of the randomized, double-blind, placebo-controlled cross-over study could have huge implications for the population of individuals over 65 that is growing at the fastest rate in history--an American turns 65 every 13 seconds; approximately 10,000 baby boomers retire every day.

The study demonstrated that GanedenBC30 supports digestive (increased healthy bacteria in the gut) and immune health (improved immune markers) in a healthy senior population.

Senior author of the study, Glenn Gibson, professor of Food Microbial Sciences at the University of Reading and president and founding member of the International Scientific Association for Probiotics and Prebiotics, said: “When you are younger, you have a healthier balance of good and bad bacteria. As people age this balance shifts, and often the bad bacteria in the gut increases. In addition, people begin to experience more gastro-intestinal (GI) issues, along with changes in immune function as the majority of your immune cells are in the gut.”

“This study has helped us gain a better understanding of how age affects the gut and to further establish that GanedenBC30 can help support GI and immune health,” said David Keller, Vice President of Scientific Operations, Ganeden Biotech.

Full results are being prepared for publication.

###

About GanedenBC30:
Ganeden Biotech’s leading probiotic, GanedenBC30 (Bacillus coagulans GBI-30, 6086), is a patented, organism that can be found in more than 80 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains used in food and beverages, GanedenBC30 is highly stable and can remain viable through processing, shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 17 published studies. GanedenBC30 has an exceptional safety record and FDA GRAS status from the United States Food and Drug Administration. For more information, please visit http://www.GanedenBC30.com.

About Ganeden Biotech:
Founded in 1997 the Cleveland, Ohio-based Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies for the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS probiotic ingredient found in more than 80 leading food and beverage products. A highly stable probiotic ingredient with physical properties that make it more stable than traditional probiotic organisms (such as Lactobacillus and Bifidobacterium); GanedenBC30 is ideally suited for almost any food, beverage or companion animal application. Ganeden's newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. It can easily be incorporated in virtually any lotion, cream, soap, shampoo or other personal care product. Ganeden is more than an ingredient supplier; Ganeden works with its clients as a partner, taking special care to add value from initial contact to product launch and beyond. For more information about Ganeden Biotech and licensing opportunities visit http://www.GanedenBiotech.com.

About Reckitt Benckiser (RB):
Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene and home.

With a purpose of delivering innovative solutions for healthier lives and happier homes, Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by brands including Digestive Advantage, MegaRed, MoveFree, Airborne, Mucinex, Lysol and Air Wick.

The company has operations in over 60 countries, with headquarters in the UK, Singapore, Dubai and Amsterdam, and sales in almost 200 countries. The company employs approximately 38,000 people worldwide. For more information, visit http://www.RB.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11065649.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
Breaking Medicine Technology: